Hard to say, I recon with the additional bad news coming (Annual Report), in my opinion this stock will hit $2 this year, but could it float back to up $3, $3.50.... hard to say. DYOR
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025